Ghoreifi, A., Alshalalfa, M., Davicioni, E., Hao, Y., Spratt, D., Karnes, R. J., … Abern, M. (2025). MP32-19 CHARACTERIZING THE ACTIVITY OF INFLAMMASOME GENES AND THEIR ASSOCIATION WITH ONCOLOGICAL OUTCOMES IN PROSTATE CANCER. In Journal of Urology (Vol. 213). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/01.ju.0001110112.97722.d8.19

Ghoreifi, Alireza, Mohammed Alshalalfa, Elai Davicioni, Yangyang Hao, Daniel Spratt, R Jeffrey Karnes, J Todd Purves, Francis M. Hughes, Judd Moul, and Michael Abern. “MP32-19 CHARACTERIZING THE ACTIVITY OF INFLAMMASOME GENES AND THEIR ASSOCIATION WITH ONCOLOGICAL OUTCOMES IN PROSTATE CANCER.” In Journal of Urology, Vol. 213. Ovid Technologies (Wolters Kluwer Health), 2025. https://doi.org/10.1097/01.ju.0001110112.97722.d8.19.

Ghoreifi A, Alshalalfa M, Davicioni E, Hao Y, Spratt D, Karnes RJ, et al. MP32-19 CHARACTERIZING THE ACTIVITY OF INFLAMMASOME GENES AND THEIR ASSOCIATION WITH ONCOLOGICAL OUTCOMES IN PROSTATE CANCER. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2025.

Ghoreifi, Alireza, et al. “MP32-19 CHARACTERIZING THE ACTIVITY OF INFLAMMASOME GENES AND THEIR ASSOCIATION WITH ONCOLOGICAL OUTCOMES IN PROSTATE CANCER.” Journal of Urology, vol. 213, no. 5S, Ovid Technologies (Wolters Kluwer Health), 2025. Crossref, doi:10.1097/01.ju.0001110112.97722.d8.19.

Ghoreifi A, Alshalalfa M, Davicioni E, Hao Y, Spratt D, Karnes RJ, Purves JT, Hughes FM, Moul J, Abern M. MP32-19 CHARACTERIZING THE ACTIVITY OF INFLAMMASOME GENES AND THEIR ASSOCIATION WITH ONCOLOGICAL OUTCOMES IN PROSTATE CANCER. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2025.